Encoded Therapeutics Raises $275 Million in Series F Financing to Advance ETX101 Through Pivotal Development and Accelerate its Precision Genetic Medicines Neurology Pipeline

Encoded announced the close of a Series F co-led by GV and another healthcare fund. Financing supports pivotal ETX101 development, manufacturing scale-up and its neurology pipeline.